Skip to main content
Clinical Trials/ACTRN12615001347550
ACTRN12615001347550
Withdrawn
未知

A randomised controlled trial in older adults with documented cognitive decline of computerised cognitive training compared to active control training on memory outcomes.

niversity of Sydney0 sites86 target enrollmentDecember 10, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Secondary prevention of cognitive decline
Sponsor
niversity of Sydney
Enrollment
86
Status
Withdrawn
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 10, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Older adults (aged 60 years or older) with documented longitudinal cognitive decline unresponsive to intervention (not attributable by illness or new medication onset): those individuals who, over the course of at least 6\-24 months and multiple neuropsychological assessments have had any memory\-related test decline by at least 0\.5SD of age\-corrected norms despite routine clinic intervention. Memory tests administered by the clinics include: WMS\-III Logical memory (I and II), the RAVLT and the Rey Complex Figure.

Exclusion Criteria

  • (1\) history, diagnosis or treatment for dementia (of any aetiology); (2\) current use of third\-generation or tricyclic antidepressants; (3\) history of stroke in last 12 months; (4\) major neurological disorder requiring current treatment (epilepsy, Parkinson's disease); (5\) major psychiatric disorder requiring current treatment (schizophrenia, bipolar disorder); (6\) physical (sensory or motor) impairment that would limit training; (7\) current undertaking of any other computerised cognitive training (CCT) program; (8\) current alcohol dependence or abuse (defined as drinking over NHMRC guidelines); (9\) definitive exclusion of possible undiagnosed major depression using the Geriatric Depression Scale (15\-item score 10 or greater) or Hamilton Rating Scale for Depression (17\-item score 12 or greater) i.e. if participants were found to have clinical depression scores at baseline measurement that were not previously diagnosed, these participants will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The Cognitive Ageing Nutrition and Neurogenesis (CANN) trial: investigating the effects of a flavonoid/fatty acid supplement on cognitive functioMild Cognitive ImpairmentSubjective Memory ImpairmentAlternative and Complementary Medicine - Other alternative and complementary medicineNeurological - Other neurological disorders
ACTRN12615001053516Swinburne Univeristy240
Not yet recruiting
Not Applicable
A lifestyle intervention to improve function and health outcomes in older adults with knee osteoarthritis: A pilot studyKnee OsteoarthritisOverweight/ObesityMusculoskeletal - OsteoarthritisDiet and Nutrition - Obesity
ACTRN12607000311459Prof Lynne Daniels52
Completed
Not Applicable
Deprescribing in frail older people: a randomised controlled trial
ACTRN12611000370909Kathleen Potter100
Terminated
Not Applicable
Managing Chronic Obstructive Pulmonary Disease(COPD)Together: Participant-CENTREd Continuum of Care (PCCC). A comparison of telephone health-mentoring, home-based walking and rehabilitation with rehabilitation only.Chronic Obstructive Pulmonary Disease (COPD)Respiratory - Chronic obstructive pulmonary diseasePhysical Medicine / Rehabilitation - Physiotherapy
ACTRN12611001034921Menzies Research Institute Tasmania, University of Tasmania74
Not yet recruiting
Not Applicable
Comparing fibreoptic-guided tracheal intubation using two supraglottic devices: Ambu AuraGain Laryngeal Mask Airway 'Registered Trademark' and LMA Fastrach 'Registered Trademark'
ACTRN12615000300572Elizabeth Judson120